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INTRODUCTION
  Every  day,  thousands  of  patients  who  present  to 
emergency departments (EDs) require tracheal intubation for 
optimal care.  Most acute intubations are performed using 
rapid sequence intubation (RSI), with the administration of 
an intravenous sedative followed by a paralytic agent, to ob-
tain the best chance for successful intubation.  Premedication 
with various agents prior to RSI when certain conditions are 
present is recommended by experts in acute airway manage-
ment, as well as by many authors of major emergency medi-
cine textbooks and advanced airway instructional courses.   
This premedication is touted as a way to limit physiologic 
responses to intubation that may adversely affect the patient.   
Despite expert opinions in favor of premedication, a paucity 
of data in the literature supports these practices.  This fact, 
combined with the chaos, anxiety, and confusion often as-
sociated with securing a critical airway, can cause the physi-
cian performing RSI to question whether the administration 
of additional medications is truly essential or simply an un-
necessary and burdensome measure.
The  central  nervous,  respiratory,  endocrine,  and 
cardiovascular  systems  all  respond  in  various  ways  to 
laryngoscopy  and  tracheal  intubation  (LTI),  and  many  of 
these responses can be harmful. See Table  .  LTI stimulates 
the  sympathetic  nervous  system  which  causes  release  of 
catecholamines and an increase in mean arterial pressure, 
heart  rate,  myocardial  and  cerebral  oxygen  consumption, 
cerebral  blood  flow,  intraocular  pressure  (IOP),  and 
intracranial pressure (ICP).  Laryngospasm, bronchospasm, 
cough, and dysrhythmias can also result.  In children, LTI will 
often lead to a paradoxical bradycardia due to stimulation of 
the vagus nerve.  These physiologic responses are worsened 
by prolonged and aggressive LTI attempts, as well as by 
stimulation  of  the  carina  with  the  endotracheal  tube.    In 


















with such conditions as myocardial ischemia, aortic dissection or 
aneurysm, head trauma, ocular trauma, traumatic bleeding, asthma, 
and chronic obstructive pulmonary disease (COPD). See Table 2. 
 
 
Table . Physiologic responses increased by laryngos- 
              copy and intubation 
_______________________________________________ 
•  Blood pressure
•  Pulse
•  Cerebral oxygen demand
•  Myocardial oxygen demand
•  Cerebral blood flow
•  Intracranial pressure






Table 2. Conditions for which pre-medication may be 
               beneficial 
______________________________________________
•  Myocardial ischemia
•  Aortic dissection
•  Aortic aneurysm
•  Head trauma
•  Ocular Trauma
•  Traumatic bleeding
•  Asthma
•  Chronic obstructive 
             pulmonary disease
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“LOAD”: Premedication To Prevent  
Potentially Harmful Physiologic Responses
Efforts to premedicate for RSI and prevent detrimental 
responses to LTI center on the use of four medications or 
classes of medications.  The mnemonic “LOAD” may be used 
to recall the pre-medication cocktail consisting of lidocaine, 
opiates  (largely  fentanyl),  atropine,  and  defasciculating 
neuromuscular blocking agents.  These agents are believed 
to  hold  the  best  hope  for  preventing  adverse  physiologic 
responses to LTI .  Recommendations are to administer pre-
medications three minutes prior to intubation. See Table 3.
Available data show that these agents are used much 
more frequently in the United States (US) than in the United 
Kingdom  (UK).    Interestingly,  this  difference  in  practice 
pattern prompted much of the research done in this area.   
A  survey  of  US  emergency  medicine  residency  program 
directors done in 995 illustrated that of the programs that 
responded, 87% used lidocaine, 8% used defasciculation, 
and 49% used fentanyl when performing RSI in adults with 
elevated ICP.  In a UK review of 60 emergency intubations, of 
which only 26% were performed by emergency physicians, no 
patients received lidocaine or defasciculation.2  This variation 
in practice patterns exemplifies the lack of consensus opinion 
and evidential support.
LIDOCAINE
Lidocaine  premedication  is  used  to  limit  rises  in 
intracranial  pressure,  intraocular  pressure,  bronchospasm, 
dysrhythmia, and cardiovascular responses, such as elevated 
heart rate and blood pressure.  Regardless of the clinical 
indication or age of the patient, it is given at a dose of .5   
mg/kg intravenously three minutes before intubation.  It has 
never been shown to produce an adverse effect.3
Despite its history of safety, little evidence supports 
premedication with lidocaine to prevent rises in ICP when 
performing RSI.  In 200, Robinson and Clancy published 
an evidence-based medicine review that addressed whether 
pretreatment with intravenous lidocaine leads to an improved 
neurological outcome in patients with head injury undergoing 
RSI.  They found no direct evidence that answered their 
query.    However,  six  studies  did  partially  address  their 
question.    These  particular  studies  were  performed  in 
patients with intracranial pressure monitors in place in an 
intensive care unit (ICU) or operating room (OR).  None 
of the studies involved ED patients.  They  were limited in 
size, with the largest involving only 22 patients.  All either 
used intubation in the OR with induction medications not 
commonly used in the ED or endotracheal suctioning in the 
ICU as the noxious stimulus.  Again, none used RSI in the 
ED.  None of the studies focused on long-term outcomes of 
clinical importance, such as improved disability or reduced 
mortality.  No studies were found that examined the use of 
lidocaine in children.4,5
  Intraocular pressure is raised by a number of factors 
often  present  during  RSI,  including  succinylcholine,  LTI, 
and patient movements such as coughing, gagging, crying, or 
combative behavior.  One study showed that premedication 
with lidocaine given at 2 mg/kg significantly attenuated the 
rise in IOP associated with intubation, but the importance 
of this rise in IOP, which averaged 5.5 mmHg, is unclear.4   
No  reports  of  vitreous  extrusion  following  RSI  with 
succinylcholine have ever been reported.6
Substantiation  for  the  use  of  lidocaine  to  reduce 
bronchospasm  in  response  to  LTI  is  also  minimal  and 
conflicting.  One study showed a reduction in bronchospasm 
when patients were exposed to inhaled histamine rather than 
LTI.7 The only study that examined bronchospasm in LTI 
showed no benefit to premedication with lidocaine.8 Once 
again, no long-term outcomes were examined in either study, 
and minimal pediatric data were collected.
Lidocaine has also been used to limit the hemodynamic 
responses  to  LTI.    In  994,  Lev  and  Rosen  performed  a 
review of the literature and found that eight of 25 studies 
showed suppression of tachycardia and hypertension; seven 
showed suppression of tachycardia only, and 0 showed no 
benefit.  Fentanyl, another agent used to limit this response, 
has shown a more consistent ability to limit hemodynamic 
surges from LTI.3,9-2
Several  studies  have  demonstrated  that  lidocaine 
can prevent dysrhythmias and electrocardiographic (ECG) 
changes induced by LTI.  The most common dysrhythmias 
and ECG changes included premature atrial and ventricular 
contractions, ST-segment depression, and T-wave inversions.   
All of these are usually transient and of questionable clinical 
significance.  No studies demonstrated adverse long-term   
Table 3. Medications used in premedication 
              during rapid sequence intubation 
________________________________________
Medication  Dose
Lidocaine  .5 mg/kg intravenously
Fentanyl  3 mcg/kg intravenously
Atropine  0.02 mg/kg intravenously
                          (minimum dose 0. mg, 
                           maximum dose  mg)
Rocuronium  0.06 mg/kg intravenously 
Vecuronium  0.0 mg/kg intravenously
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outcomes associated with the occurrence of these transient 
reactions to LTI.3
Overall, compelling evidence exists advocating the 
safety of lidocaine when used in premedication prior to RSI, 
but little or conflicting evidence suggests it has a definite and 
important clinical effect in preventing hemodynamic surges, 
bronchospasm, rises in intracranial pressure, or dysrhythmias 
induced by LTI.
OPIOIDS (FENTANYL)
Although fentanyl is poor at preventing the tachycardia 
from LTI, its status as the most effective agent to reduce the 
hypertension associated with LTI has been documented in 
multiple studies with LTI in the OR.9-2  The typical dose 
is 3 mcg/kg of fentanyl intravenously three minutes prior 
to intubation.  It is usually advocated for patients in whom 
hypertension can be particularly dangerous, such as those with 
elevated ICP, intracranial hemorrhage or cerebral aneurysm, 
ischemic heart disease, and aortic aneurysm or dissection.  No 
studies examined long-term benefits associated with its use. 
Fentanyl is a powerful agent that must be dispensed 
appropriately.    It  should  be  the  last  premedication  agent 
prescribed, as it has the potential to cause hypotension, and 
should be administered within a 30- to 60-second timeframe.   
Doses  greater  than  5  mcg/kg  have  been  associated  with 
hypotension in  to 45 percent of patients.0 Consequently, 
caution  must  be  used  when  it  is  given  to  patients  with 
hypotension or hypovolemia.  Muscular rigidity associated 
with fentanyl is associated with rapidly administered doses 
greater than 500 mcg.  Adhering to slow administration and 
doses of 3 mcg/kg should prevent these complications.
Esmolol is another agent sometimes used to blunt 
the hemodynamic response to LTI.3  Although effective in 
reducing the occurrence of both hypertension and tachycardia 
(unlike fentanyl), it has an increased incidence of adverse 
effects, such as negative inotropy and bronchoconstriction, 
when compared with fentanyl.  Its clinical use, therefore, is 
limited.
ATROPINE
Bradycardia  is  thought  to  arise  when  children  are 
intubated  due  to  stimulation  of  the  vagus  nerve  by  LTI.   
Succinylcholine may also cause a drop in heart rate.  Most major 
pediatric  emergency  texts  and  airway  courses  recommend 
0.02 mg/kg of intravenous atropine three minutes prior to 
intubation with succinylcholine to prevent this bradycardia 
in all children between 5 to 0 years of age.  According to the 
literature, most studies that support its use were conducted 
in the OR and involved repeat dosing of succinylcholine, a 
practice that is rare and not recommended in the ED.  
The  largest  study  examining  the  use  of  atropine 
as  a  premedication  was  a  retrospective  review  of  43 
pediatric ED intubations.  Sixty-eight patients in this study 
received  atropine  prior  to  intubation,  while  75  received 
no premedication.  Bradycardia was a rare event: only six 
patients developed the condition, three from each group.   
There  was  no  statistically  significant  difference  in  the 
occurrence of bradycardia between children who did and 
did not receive atropine.  There was, however, a statistically 
significant  difference  in  rates  of  hypoxia.    Twenty-eight 
percent of the atropine group versus 6% of the non-atropine 
group (p = 0.046) became hypoxic.4
These results suggest that atropine administration, 
although uniformly recommended, may not be necessary.   
Bradycardia is a relatively rare phenomenon, and atropine 
may  not  offer  protection  against  its  occurrence.    This 
recommendation has never been subjected to randomized 
clinical  trials  in  the  ED,  causing  some  to  question  the 
necessicity of this step.
DEFASCICULATION MEDICATIONS
Some evidence demonstrates that the administration 
of succinylcholine raises ICP.  Traditionally, premedication 
with a non-depolarizing neuromuscular blocking agent three 
minutes before RSI with succinylcholine was recommended 
in patients who might be adversely affected by a rise in 
ICP.  Pretreatment agents commonly used are 0.06 mg/kg 
of rocuronium and 0.0 mg/kg of vecuronium administered 
intravenously.
Most of the evidence supporting the use of these 
agents  comes  from  intubations  in  the  OR.    One  study 
looked  at  2  patients  undergoing  craniotomy  for  tumor 
excision: six received a pretreatment dose of metocurine, a 
non-depolarizing neuromuscular blocker, and six received 
a placebo prior to intubation with  mg/kg of intravenous 
succinylcholine.  The placebo group experienced a rise in 
ICP of  to 23 mmHg, while the ICP did not rise in the 
metocurine group.6
Another study was done wherein 3 patients with 
brain  tumors  who  were  being  mask  ventilated  were  first 
administered succinylcholine, after which their ICP rose an 
average of 5 mmHg, with 5 patients rising 9 mmHg or greater.   
After  the  ICP  measurements  were  recorded,  the  patients 
were intubated and stabilized until neuromuscular function 
returned to normal.  They were subsequently given a full 
paralyzing dose of vecuronium, in contrast to a pretreatment 
dose, and were again given succinylcholine while already 
intubated.  The pretreatment with a full paralyzing dose of 
vecuronium prevented the rise in ICP associated with the 
administration of succinylcholine.  However, if the doses 
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subsequent dose of succinylcholine would not be necessary, 
as  the  vecuronium  alone  would  adequately  paralyze  the 
patient.  In addition, the patients in this study had already 
been intubated prior to the vecuronium administration.  Thus 
it was not a true premedication before intubation.7
While  some  evidence  shows  that  defasciculation 
prevents  rises  in  ICP  associated  with  succinylcholine 
administration,  the  evidence  is  limited.    In  addition, 
pretreatment  with  defasciculating  agents  can  rarely  cause 
premature apnea before the physician is ready to intubate.   
If vecuronium is used, an additional step is needed, since 
reconstitution is required before its use.
As previously mentioned in the lidocaine subsection, 
the  administration  of  succinylcholine  has  been  associated 
with a rise in IOP of 3 to 8 mmHg.8  Defasciculation prior 
to  the  administration  of  succinylcholine  in  patients  with 
penetrating ocular trauma has been recommended.  However, 
there has never been a case report of vitreous extrusion in RSI 
with succinylcholine despite its extensive use.  The clinical 
importance of these rises in IOP is unclear.6  In addition, 
patient movements such as coughing, gagging, or combative 
behaviors, have been associated with much higher elevations 
of IOP and are eliminated by the paralysis induced during 
RSI.8
SUMMARY
Although  premedication  when  performing  RSI  is 
often recommended, data supporting the use of these agents 
are limited.  Very few studies have been performed using 
acute intubations with RSI in the ED, and no improvement 
in outcomes has ever been demonstrated.  When physicians 
performing  RSI  decide  to  include  premedication  in  their 
regimen,  a  number  of  standard  references  can  be  found 
supporting their practice.  Physicians who perform RSI with 
a  simpler  approach,  electing  not  to  utilize  premedication, 
should  also  feel  validated,  as  there  is  a  lack  of  research 
demonstrating improved clinical outcomes associated with 
premedication  in  RSI.    Randomized,  placebo-controlled 
clinical  trials  addressing  important  outcomes,  such  as 
neurologic function or death, in patients undergoing RSI in 
the ED are needed to examine the utility of premedication 
during RSI.
The views expressed in this article are those of the author and 
do not reflect the official policy or position of the Department 
of the Navy, Department of Defense, or the United States 
Government.
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